Details for New Drug Application (NDA): 081008
✉ Email this page to a colleague
NDA 081008 describes STRIFON FORTE DSC, which is a drug marketed by Ferndale Labs and is included in one NDA. Additional details are available on the STRIFON FORTE DSC profile page.
The generic ingredient in STRIFON FORTE DSC is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
The generic ingredient in STRIFON FORTE DSC is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 081008
| Tradename: | STRIFON FORTE DSC |
| Applicant: | Ferndale Labs |
| Ingredient: | chlorzoxazone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 081008
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Dec 23, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
